Evidence-Based Medicine Guidelines
Betahistine for Ménière's disease and vertigo
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Betahistine for Ménière's Disease and Vertigo." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/452838/all/_Betahistine_for_Ménière's_disease_and_vertigo.
Betahistine for Ménière's disease and vertigo. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/452838/all/_Betahistine_for_Ménière's_disease_and_vertigo. Accessed April 19, 2024.
Betahistine for Ménière's disease and vertigo. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/452838/all/_Betahistine_for_Ménière's_disease_and_vertigo
Betahistine for Ménière's Disease and Vertigo [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2024 April 19]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/452838/all/_Betahistine_for_Ménière's_disease_and_vertigo.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Betahistine for Ménière's disease and vertigo
ID - 452838
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/452838/all/_Betahistine_for_Ménière's_disease_and_vertigo
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
